Health Care: Drugs

Orexigen Therapeutics Inc (OREX: NASDAQ)

$3.03 -0.09 | -2.88%
06/26/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.12
52 Week High 5.70
52 Week Low 1.65
Avg. Daily Vol. (Mil) 0.18
Beta (3 year) 2.81
Share Related Items
Mkt Cap (Mil) 47.51
Shares Out (Mil) 15.23
Float (Mil) 8.37
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.90
Current Ratio 3.20
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.99
Price/Book 0.00
Price/Cash Flow -0.80
Per Share Data
Earnings -6.97
Sales 3.14
Book Value 0.00
Cash Flow -4.02
Business Summary
Orexigen Therapeutics Inc is an emerging pharmaceutical company. The company is developing neuroscience drugs that will ultimately address obesity and weight related medical issues.
General Information
3344 North Torrey Pines Cour
Suite 200
La Jolla, CA 92037
www.orexigen.com
Industry : Drugs
Sector: Health Care
Employees: 132
CEO: Michael A. Narachi
Short Interest
Current Month (Mil) 2.57
Previous Month (Mil) 2.46
Short Interest Ratio (Days) 21.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -30.10
Return on Investments -42.10
Profitability
Gross Margin 80.30
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OREX

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter